William Chamberlin
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 12
- Mycobacterium research and diagnosis 8
- Genetics 8
- Inflammatory Bowel Disease 7
- Co-authors
- Saleh A. Naser (3 shared papers)Rodrick J. Chiodini (3 shared papers)Catherine Nathan (3 shared papers)Robert A. Weinstein (3 shared papers)S. A. Kabins (3 shared papers)Richard W. McCallum (3 shared papers)Ira Shafran (2 shared papers)Jerzy Sarosiek (2 shared papers)
- Journals
- The Journal of Infectious Diseases (3 papers)Journal of Clinical Gastroenterology (2 papers)Drugs of today (1 paper)Clinical & Experimental Immunology (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesAustraliaBrazil
In The Last Decade
William Chamberlin
27 papers receiving 976 citations
Peers
Comparison fields: 5 of 113
- Molecular Medicine 119
- Applied Microbiology and Biotechnology 44
- Critical Care and Intensive Care Medicine 73
- Epidemiology 474
- Small Animals 97
Countries citing papers authored by William Chamberlin
This map shows the geographic impact of William Chamberlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Chamberlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Chamberlin more than expected).
Fields of papers citing papers by William Chamberlin
This network shows the impact of papers produced by William Chamberlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Chamberlin. The network helps show where William Chamberlin may publish in the future.
Co-authors
The 25 scholars most cited alongside William Chamberlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 139 | |
| 2 | 2015 | 124 | |
| 3 | 1984 | 123 | |
| 4 | 2012 | 121 | |
| 5 | 2000 | 106 | |
| 6 | 1989 | 69 | |
| 7 | Integrating theories of the etiology of Crohn's disease. On the etiology of Crohn's disease: questioning the hypotheses. | 2006 | 58 |
| 8 | 1973 | 48 | |
| 9 | 1974 | 48 | |
| 10 | 1985 | 41 | |
| 11 | 2020 | 38 | |
| 12 | 1991 | 25 | |
| 13 | 2011 | 20 | |
| 14 | 2013 | 17 | |
| 15 | 2012 | 15 | |
| 16 | 2021 | 12 | |
| 17 | 1990 | 8 | |
| 18 | 1984 | 7 | |
| 19 | 1995 | 6 | |
| 20 | 2001 | 5 |
About William Chamberlin
William Chamberlin is a scholar working on Epidemiology, Genetics, Infectious Diseases, Surgery and Molecular Biology, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (8 papers), Inflammatory Bowel Disease (7 papers), Tuberculosis Research and Epidemiology (4 papers), Pharmacological Effects of Natural Compounds (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Immune Cell Function and Interaction (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Molecular Medicine (119 citations), Applied Microbiology and Biotechnology (44 citations), Critical Care and Intensive Care Medicine (73 citations), Epidemiology (474 citations) and Small Animals (97 citations). William Chamberlin has collaborated with scholars based in United States, Australia and Brazil. Frequent co-authors include Saleh A. Naser, Rodrick J. Chiodini, Catherine Nathan, Robert A. Weinstein, S. A. Kabins, Richard W. McCallum, Ira Shafran, Jerzy Sarosiek, Susan Galandiuk and Brian R. Davis. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Clinical Gastroenterology, Drugs of today, Clinical & Experimental Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.